HeshaamMirMDMBA

Research • Foster City, CA

Gilead Sciences

Join to view full profile

Dr. Mir is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mir's full profile

Already have an account?

Office
333 Lakeside Drive
Foster City, CA 94404
Is this information wrong?

Clinical Trials

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection Start of enrollment: 2013 Jan 01
Completed
Phase 3
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3) Start of enrollment: 2013 May 01
Completed
Phase 3
Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection Start of enrollment: 2013 Oct 01
Completed
Phase 2

Publications & Presentations

PubMed

29 citations
Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies.
Jason Grebely, Jordan J. Feld, David L. Wyles, Mark S. Sulkowski, Liyun Ni, Joe Llewellyn, Heshaam M Mir, Nika Sajed, Luisa M. Stamm, Robert H. Hyland, John McNally, D...> ;Open Forum Infectious Diseases. 2018 Feb 1
107 citations
Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
Zobair M. Younossi, Mendel E. Singer, Heshaam M. Mir, Linda Henry, Sharon L. Hunt> ;Journal of Hepatology. 2014 Mar 1
31 citations
Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study.
Heshaam M. Mir, Maria Stepanova, Hena Afendy, Rebecca Cable, Zobair M. Younossi> ;Journal of Clinical and Experimental Hepatology. 2013 Sep 1
21 citations
Mortality associated with alcohol-related liver disease.
Gregory Trimble, L. Zheng, Alita Mishra, Shirley Kalwaney, Heshaam M. Mir, Zobair M. Younossi> ;Alimentary Pharmacology & Therapeutics. 2013 Sep 1
55 citations
Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C.
Zobair M. Younossi, L. Zheng, Maria Stepanova, Chapy Venkatesan, Heshaam M. Mir> ;Alimentary Pharmacology & Therapeutics. 2013 Apr 1
69 citations
Association of chronic liver disease with depression: a population-based study.
Keanu Lee, Munkhzul Otgonsuren, Zahra Younoszai, Heshaam M. Mir, Zobair M. Younossi> ;Psychosomatics. 2013 Jan 1
12 citations
African americans are less likely to have clearance of hepatitis C virus infection: the findings from recent U.S. population data.
Heshaam M. Mir, Maria Stepanova, Mariam Afendy, Marcelo Kugelmas, Zobair M. Younossi> ;Journal of Clinical Gastroenterology. 2012 Sep 1
776 citations
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.
Zobair M. Younossi, Maria Stepanova, Mariam Afendy, Yun Fang, Youssef Younossi, Hesham Mir, Manirath K. Srishord> ;Clinical Gastroenterology and Hepatology. 2011 Jun 1
6 citations
Monoclonal and Polyclonal Antibodies Against the HCV Envelope Proteins
Heshaam M. Mir, Aybike Birerdinc, Zobair M. Younossi> ;Clinics in Liver Disease. 2009 Aug 1
Join now to see all

Journal Articles

Association of Sleep Disorders with Nonalcoholic Fatty Liver: A Population-Based Study
Mir HM, Stepanova M, Afendy H, Cable R, Younossi ZM, Journal of Clinical and Experimental Hepatology., 9/2013

External Links

LinkedInhttps://www.linkedin.com/pub/heshaam-mir-md/73/8b7/6a2

HeshaamMirMDMBA

Dr. Mir is on Doximity

Clinical Trials

Publications & Presentations

External Links

Viewing the full profile is available to verified healthcare professionals only.